Fortress Biotech, Inc. (FBIO) Total liabilities 2016–2025
Fortress Biotech, Inc. (FBIO) total liabilities at each fiscal year-end, per SEC filings.
$123.4MFY2025 · since FY2016: $87.8M → $123.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $123.4M | -15.4% |
| FY2024 | $145.9M | -12.1% |
| FY2023 | $165.9M | -32.1% |
| FY2022 | $244.3M | +43.2% |
| FY2021 | $170.6M | +25.1% |
| FY2020 | $136.4M | -11.4% |
| FY2019 | $153.9M | +26.9% |
| FY2018 | $121.3M | -3.3% |
| FY2017 | $125.4M | +42.9% |
| FY2016 | $87.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice